Matches in SemOpenAlex for { <https://semopenalex.org/work/W1982389043> ?p ?o ?g. }
- W1982389043 endingPage "559" @default.
- W1982389043 startingPage "550" @default.
- W1982389043 abstract "Objectives: A validated canine critical-sized segmental defect model was used to compare efficacy of volumetric ratios of recombinant human bone morphogenetic protein-2 (rhBMP-2)/absorbable collagen sponge (ACS) with cancellous allograft bone or biphasic calcium phosphate ceramic granules using radiographic, biomechanical, and histologic analyses. Methods: Eighteen mixed-breed hounds received bilateral critical-sized ulnar segmental defects. The six treatment groups included 1:5, 1:2, and 1:1 volumetric ratios of rhBMP-2/ACS to cancellous allograft chips; a 1:1 volumetric ratio of rhBMP-2/ACS to biphasic calcium phosphate ceramic granules; iliac crest autograft alone; and cancellous allograft chips alone (n = 6 ulna per group). Animals were euthanized at 12 weeks and analyzed by radiography, torsion testing, and histology. Results: rhBMP-2/ACS groups demonstrated higher radiographic union than autograft or allograft at 12 weeks. Both treatment groups receiving a 1:1 ratio demonstrated union rates of 100% (12/12 ulna) compared with 17% (1/6) and 0% (0/6) for autograft and allograft, respectively. Torsion testing to failure demonstrated significant increases in maximum torque for all rhBMP-2 groups compared with autograft, but no differences between the rhBMP-2 groups. Ulnae treated with the 1:1 volume ratio of rhBMP-2/ACS to ceramic had the highest histologic union grades followed by 1:1 and 1:2 volume ratios of rhBMP-2/ACS to allograft. Conclusions: In this study, efficacy of the treatment correlated with the ratio of rhBMP-2/ACS to allograft. As volume of rhBMP-2/ACS decreased below a 1:1 volume ratio, the overall efficacy decreased, thus indicating a potential limit to extending rhBMP-2/ACS past a 1:1 volumetric ratio in large segmental defects. Furthermore, ceramic was found to be a successful replacement for cancellous allograft bone at a 1:1 volumetric ratio. Clinical application using graft expanders or bone void fillers with rhBMP-2 should be used carefully and requires further investigation." @default.
- W1982389043 created "2016-06-24" @default.
- W1982389043 creator A5028094383 @default.
- W1982389043 creator A5044855998 @default.
- W1982389043 creator A5053705234 @default.
- W1982389043 creator A5054306832 @default.
- W1982389043 creator A5075666212 @default.
- W1982389043 date "2008-09-01" @default.
- W1982389043 modified "2023-09-25" @default.
- W1982389043 title "Improved Healing Efficacy in Canine Ulnar Segmental Defects With Increasing Recombinant Human Bone Morphogenetic Protein-2/Allograft Ratios" @default.
- W1982389043 cites W130903943 @default.
- W1982389043 cites W1508777555 @default.
- W1982389043 cites W1944831456 @default.
- W1982389043 cites W1962351050 @default.
- W1982389043 cites W1968822620 @default.
- W1982389043 cites W1973158119 @default.
- W1982389043 cites W1986469118 @default.
- W1982389043 cites W2001696158 @default.
- W1982389043 cites W2003521990 @default.
- W1982389043 cites W2006234957 @default.
- W1982389043 cites W2006664288 @default.
- W1982389043 cites W2010318332 @default.
- W1982389043 cites W2011949885 @default.
- W1982389043 cites W2012757283 @default.
- W1982389043 cites W2015668670 @default.
- W1982389043 cites W2018820156 @default.
- W1982389043 cites W2029415593 @default.
- W1982389043 cites W2033227999 @default.
- W1982389043 cites W2034614189 @default.
- W1982389043 cites W2055160842 @default.
- W1982389043 cites W2056984915 @default.
- W1982389043 cites W2058111914 @default.
- W1982389043 cites W2060288350 @default.
- W1982389043 cites W2069910966 @default.
- W1982389043 cites W2073732562 @default.
- W1982389043 cites W2084679051 @default.
- W1982389043 cites W2093654042 @default.
- W1982389043 cites W2102618636 @default.
- W1982389043 cites W2131707650 @default.
- W1982389043 cites W2144395489 @default.
- W1982389043 cites W2161845595 @default.
- W1982389043 cites W2166650033 @default.
- W1982389043 cites W2229813099 @default.
- W1982389043 cites W2291430305 @default.
- W1982389043 cites W2395266724 @default.
- W1982389043 cites W2412578509 @default.
- W1982389043 cites W3000473592 @default.
- W1982389043 cites W4205199355 @default.
- W1982389043 cites W4234223163 @default.
- W1982389043 cites W4252530191 @default.
- W1982389043 cites W4295850198 @default.
- W1982389043 cites W4322702925 @default.
- W1982389043 cites W76598284 @default.
- W1982389043 doi "https://doi.org/10.1097/bot.0b013e318180f0f0" @default.
- W1982389043 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18758287" @default.
- W1982389043 hasPublicationYear "2008" @default.
- W1982389043 type Work @default.
- W1982389043 sameAs 1982389043 @default.
- W1982389043 citedByCount "29" @default.
- W1982389043 countsByYear W19823890432012 @default.
- W1982389043 countsByYear W19823890432013 @default.
- W1982389043 countsByYear W19823890432014 @default.
- W1982389043 countsByYear W19823890432015 @default.
- W1982389043 countsByYear W19823890432016 @default.
- W1982389043 countsByYear W19823890432017 @default.
- W1982389043 countsByYear W19823890432018 @default.
- W1982389043 countsByYear W19823890432020 @default.
- W1982389043 countsByYear W19823890432021 @default.
- W1982389043 countsByYear W19823890432022 @default.
- W1982389043 crossrefType "journal-article" @default.
- W1982389043 hasAuthorship W1982389043A5028094383 @default.
- W1982389043 hasAuthorship W1982389043A5044855998 @default.
- W1982389043 hasAuthorship W1982389043A5053705234 @default.
- W1982389043 hasAuthorship W1982389043A5054306832 @default.
- W1982389043 hasAuthorship W1982389043A5075666212 @default.
- W1982389043 hasConcept C104317684 @default.
- W1982389043 hasConcept C126894567 @default.
- W1982389043 hasConcept C141071460 @default.
- W1982389043 hasConcept C185592680 @default.
- W1982389043 hasConcept C202751555 @default.
- W1982389043 hasConcept C2776350087 @default.
- W1982389043 hasConcept C2779079599 @default.
- W1982389043 hasConcept C2911091166 @default.
- W1982389043 hasConcept C30352789 @default.
- W1982389043 hasConcept C31507581 @default.
- W1982389043 hasConcept C55493867 @default.
- W1982389043 hasConcept C71924100 @default.
- W1982389043 hasConcept C8337478 @default.
- W1982389043 hasConceptScore W1982389043C104317684 @default.
- W1982389043 hasConceptScore W1982389043C126894567 @default.
- W1982389043 hasConceptScore W1982389043C141071460 @default.
- W1982389043 hasConceptScore W1982389043C185592680 @default.
- W1982389043 hasConceptScore W1982389043C202751555 @default.
- W1982389043 hasConceptScore W1982389043C2776350087 @default.
- W1982389043 hasConceptScore W1982389043C2779079599 @default.
- W1982389043 hasConceptScore W1982389043C2911091166 @default.
- W1982389043 hasConceptScore W1982389043C30352789 @default.
- W1982389043 hasConceptScore W1982389043C31507581 @default.